ANALYSIS OF THE INITIAL EVENTS IN THE IN VIVO REPLICATION OF POLIOVIRUS RNA
脊髓灰质炎病毒 RNA 体内复制初始事件的分析
基本信息
- 批准号:3804810
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Attenuation of neurovirulence in poliovirus appears to be the results of
a finite number of nucleotide changes in the viral genome that cause a
decrease in the replicative efficiency of the virus. Despite this, the
attenuation phenotype can be pleiotropic and difficult to analyze.
Differences in replicative efficiency, especially for picornaviruses,
should be most pronounced during the initial stages of viral infection
when the infecting viral genome initiates the events that lead to the
subversion of the cell. We have demonstrated that the low level of
poliovirus replication during the expression of the infecting viral genome
can be monitored by following the appearance of viral RNA complementary to
virion RNA (cRNA). Cellular amplification of virion RNA requires cRNA,
which is found neither in virions nor in uninfected cells. Extremely low
levels of cRNA have been detected and quantitated using radioactive probes
for cRNA and RNA purified from cells early in the infectious cycle. These
studies have been extended and simplified through the use of the
polymerase chain reaction (PCR), which is being used to delineate the
progression of the viral RNA through the initial stages of viral
infection.
脊髓灰质炎病毒神经毒力的减弱似乎是以下因素的结果:
病毒基因组中有限数量的核苷酸变化,
降低病毒的复制效率。 尽管如此,
减毒表型可能是多效性的并且难以分析。
复制效率的差异,特别是对于小核糖核酸病毒,
在病毒感染的最初阶段应该最明显
当感染病毒的基因组启动导致
颠覆细胞。 我们已经证明,低水平的
脊髓灰质炎病毒在感染病毒基因组表达期间的复制
可以通过观察病毒RNA的出现来监测
病毒体RNA(cRNA)。 病毒体RNA的细胞扩增需要cRNA,
其既不存在于病毒体中,也不存在于未感染的细胞中。 极低
使用放射性探针检测和定量cRNA水平
cRNA和从感染周期早期的细胞中纯化的RNA。 这些
研究已经扩展和简化,通过使用
聚合酶链反应(PCR),这是用来描绘
病毒RNA在病毒初始阶段的进展
感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R E LUNDQUIST其他文献
R E LUNDQUIST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R E LUNDQUIST', 18)}}的其他基金
STANDARDIZATION OF POTENCY TEST METHODS FOR IPV-WHO STUDY
IPV-WHO 研究效力测试方法的标准化
- 批准号:
5200709 - 财政年份:
- 资助金额:
-- - 项目类别:
STABILIZATION OF ORAL POLIOVIRUS VACCINE INFECTIVITY TO LYOPHILIZATION
口服脊髓灰质炎病毒疫苗冻干感染性的稳定
- 批准号:
2336433 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO TRANSLATION AS A PROBE FOR THE MECHANISM OF POL
体外翻译作为 POL 机制的探针
- 批准号:
6547096 - 财政年份:
- 资助金额:
-- - 项目类别:
STABILIZATION OF ORAL POLIOVIRUS VACCINE INFECTIVITY TO LYOPHILIZATION
口服脊髓灰质炎病毒疫苗冻干感染性的稳定
- 批准号:
3770310 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO TRANSLATION OF WILD-TYPE AND ATTENUATED POLIOVIRUS GENOMES
野生型和减毒型脊髓灰质炎病毒基因组的体外翻译
- 批准号:
3792548 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO TRANSLATION AS A PROBE FOR THE MECHANISM OF POLIOVIRUS ATTENUATION
体外翻译作为脊髓灰质炎病毒减毒机制的探针
- 批准号:
3748141 - 财政年份:
- 资助金额:
-- - 项目类别:
STANDARDIZATION OF POTENCY TEST METHODS FOR IPV-WHO STUDY
IPV-WHO 研究效力测试方法的标准化
- 批准号:
3748142 - 财政年份:
- 资助金额:
-- - 项目类别:
STABILIZATION OF POLIOVIRUS INFECTIVITY TO LYOPHILIZATION
冻干脊髓灰质炎病毒感染性的稳定
- 批准号:
3792549 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Resolving Spatiotemporal Dynamics of Recombinant Poliovirus Immunotherapy
解决重组脊髓灰质炎病毒免疫疗法的时空动力学问题
- 批准号:
10676548 - 财政年份:2023
- 资助金额:
-- - 项目类别:
In situ structural analysis of poliovirus during uncoating and encapsidation
脊髓灰质炎病毒脱壳和包壳过程中的原位结构分析
- 批准号:
473850 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Fellowship Programs
Design, synthesis and testing of oxidatively robust inhibitors for cysteine proteases in SARS2 virus and poliovirus
SARS2 病毒和脊髓灰质炎病毒半胱氨酸蛋白酶的氧化稳健抑制剂的设计、合成和测试
- 批准号:
469286 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Operating Grants
Study of the long-term immunogenicity of a combined diphteria, tetanus, acellular pertussis with a Sabin strain derived inactivated poliovirus vaccine
白喉、破伤风、无细胞百日咳联合沙宾株灭活脊髓灰质炎病毒疫苗的长期免疫原性研究
- 批准号:
22K17345 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel treatment for neuroblastoma by live-attenuated poliovirus
减毒活脊髓灰质炎病毒治疗神经母细胞瘤的新方法
- 批准号:
21K07862 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Lysine acetylation of ribosomal proteins during poliovirus infection limits viral translation
脊髓灰质炎病毒感染期间核糖体蛋白的赖氨酸乙酰化限制了病毒翻译
- 批准号:
10092928 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Lysine acetylation of ribosomal proteins during poliovirus infection limits viral translation
脊髓灰质炎病毒感染期间核糖体蛋白的赖氨酸乙酰化限制了病毒翻译
- 批准号:
9896367 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Novel Combination Immunotherapy for Non-Small Cell Lung Cancer Targeting Poliovirus Receptor
针对脊髓灰质炎病毒受体的非小细胞肺癌新型联合免疫疗法
- 批准号:
19K16837 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
New tools for the rapid analysis of Poliovirus genomic surveillance data
用于快速分析脊髓灰质炎病毒基因组监测数据的新工具
- 批准号:
2683235 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Studentship
Novel treatment for neuroblastoma by using live-attenuated poliovirus
使用减毒活脊髓灰质炎病毒治疗神经母细胞瘤的新方法
- 批准号:
18K07817 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)